Literature DB >> 14623134

Neuroprotective effect of the neurotensin analogue JMV-449 in a mouse model of permanent middle cerebral ischaemia.

Lars Torup1, Jeanett Borsdal, Thomas Sager.   

Abstract

The neuroprotective effect of the neurotensin analogue H-Lys-psi(CH2NH)Lys-Pro-Tyr-Ile-Leu-OH (JMV-449) was assessed in a mouse model of permanent distal middle cerebral artery occlusion. Mice were injected with 0.6 nmol JMV-449 or vehicle i.c.v. immediately after ischaemia. The core temperature declined by 6-7 degrees C after 30 min and the hypothermia persisted for 4-5 h. JMV-449 treatment was able to reduce the infarct volume significantly both at 24 h and 14 days after onset of ischaemia. No neuroprotective effect could be seen if the mice were kept normothermic after the JMV-449 treatment suggesting that the neuroprotective effect is mediated via the hypothermia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14623134     DOI: 10.1016/j.neulet.2003.08.008

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

Review 1.  The role of neurotensin in central nervous system pathophysiology: what is the evidence?

Authors:  Fannie St-Gelais; Claudia Jomphe; Louis-Eric Trudeau
Journal:  J Psychiatry Neurosci       Date:  2006-07       Impact factor: 6.186

2.  A novel stroke therapy of pharmacologically induced hypothermia after focal cerebral ischemia in mice.

Authors:  Ko-Eun Choi; Casey L Hall; Jin-Mei Sun; Ling Wei; Osama Mohamad; Thomas A Dix; Shan P Yu
Journal:  FASEB J       Date:  2012-03-29       Impact factor: 5.191

3.  The discovery of indole full agonists of the neurotensin receptor 1 (NTSR1).

Authors:  Paolo Di Fruscia; Yuanjun He; Marcel Koenig; Sahba Tabrizifard; Ainhoa Nieto; Patricia H McDonald; Theodore M Kamenecka
Journal:  Bioorg Med Chem Lett       Date:  2014-06-20       Impact factor: 2.823

4.  When hypothermia meets hypotension and hyperglycemia: the diverse effects of adenosine 5'-monophosphate on cerebral ischemia in rats.

Authors:  Feng Zhang; Suping Wang; Yumin Luo; Xunming Ji; Edwin M Nemoto; Jun Chen
Journal:  J Cereb Blood Flow Metab       Date:  2009-03-25       Impact factor: 6.200

5.  ML314: A Biased Neurotensin Receptor Ligand for Methamphetamine Abuse.

Authors:  Larry S Barak; Yushi Bai; Sean Peterson; Tama Evron; Nikhil M Urs; Satyamaheshwar Peddibhotla; Michael P Hedrick; Paul Hershberger; Patrick R Maloney; Thomas D Y Chung; Ramona M Rodriguiz; William C Wetsel; James B Thomas; Glen R Hanson; Anthony B Pinkerton; Marc G Caron
Journal:  ACS Chem Biol       Date:  2016-05-05       Impact factor: 5.100

Review 6.  Drug-induced hypothermia in stroke models: does it always protect?

Authors:  Meijuan Zhang; Haiying Wang; Jinbing Zhao; Cong Chen; Rehana K Leak; Yun Xu; Peter Vosler; Jun Chen; Yanqin Gao; Feng Zhang
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-05-01       Impact factor: 4.388

Review 7.  Neuroprotective mechanisms and translational potential of therapeutic hypothermia in the treatment of ischemic stroke.

Authors:  Jin Hwan Lee; James Zhang; Shan Ping Yu
Journal:  Neural Regen Res       Date:  2017-03       Impact factor: 5.135

8.  Diverse roles of neurotensin agonists in the central nervous system.

Authors:  Mona Boules; Zhimin Li; Kristin Smith; Paul Fredrickson; Elliott Richelson
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-22       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.